Orbimed Advisors LLC Graphite Bio, Inc. Transaction History

Orbimed Advisors LLC

  • $4.15 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.14 - $5.23 $1.54 Million - $3.75 Million
-717,400 Reduced 45.82%
848,412 $2.33 Million
Q4 2021

Feb 14, 2022
BUY
$8.41 - $16.71 $974,786 - $1.94 Million
115,908 Added 7.99%
1,565,812 $19.5 Million
Q3 2021

Nov 15, 2021
BUY
$15.81 - $28.39 $5.43 Million - $9.75 Million
343,597 Added 31.06%
1,449,904 $23.8 Million
Q2 2021

Aug 16, 2021
BUY
$18.5 - $30.73 $20.5 Million - $34 Million
1,106,307 New
1,106,307 $34 Million

Others Institutions Holding GRPH

# of Institutions
3
Shares Held
637K
Call Options Held
0
Put Options Held
0
View Full List

About Graphite Bio, Inc.

GRPH Quotes by TradingView
  • Ticker GRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,211,200
  • Description
  • Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...
More about GRPH
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email